Contracts › 75A50122F33003
75A50122F33003: Anthrax AV7909 Boost Evaluation and Antigen-Sparing Trial (ABEAST)
Awarded to Rho Federal Systems Division Inc by Office of Assistant Secretary for Preparedness and Response.
$3.8Mobligated
$3.9Mpotential value
18 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50122F33003 |
|---|---|
| Vehicle | 75A50120D00015 |
| Awardee | Rho Federal Systems Division Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | NC |
| Period of performance | 19 September 2022 to 18 September 2027 |
| Potential end | 18 September 2027 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record